Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer
The International Journal of Biological Markers · 2019-03 · 34 (1) · 60-68
DOI: 10.1177/1724600818820679 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The International Journal of Biological Markers, online erschienen am 11.03.2019. Verfasst von Winesh Ramphal und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Surgery Amphia Hospital Breda, the Netherlands. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoembryonic Antigen, Colorectal Neoplasms, Colorectal Surgery. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Introduction
Serum carcinoembryonic (CEA) antigen is used as a diagnostic screening tool during follow-up in colorectal cancer patients. However, it remains unclear whether preoperative serum CEA is a reliable marker in the follow-up to predict recurrence. The aim of the study is to determine the value of elevated pre- and postoperative serum carcinoembryonic antigen levels (CEA > 5 µg/L) as an independent prognostic factor for locoregional and distant recurrence in patients who underwent curative surgery for colorectal cancer.
Methods
This single center retrospective observational cohort study includes patients who underwent curative surgery for colorectal cancer between 2005 and 2015 and had pre- and postoperative serum CEA measurements. Five-year disease-free survival and multivariate Cox regression analyses were performed to adjust for confounding factors.
Results
Preoperative serum CEA level was measured in 2093 patients with colorectal cancer. No significant association was found between an elevated preoperative serum CEA and locoregional recurrence (adjusted hazard ratio (HR) 1.29 (95% confidence interval (CI) 0.91, 1.84; P=0.26)). However, a significant association was found between an elevated preoperative serum CEA and systemic recurrence (adjusted HR 1.58 (95% CI 1.25, 2.00; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Surgery Amphia Hospital Breda, the Netherlands.
- 2 Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
- 3 GROW: School of Oncology and Developmental Biology, University of Maastricht, Maastricht, the Netherlands.
Zitieren
APA
Ramphal, W., Boeding, J. R. E., van Iwaarden, M., Schreinemakers, J. M. J., Rutten, H. J. T., Crolla, R. M. P. H., & Gobardhan, P. D. (2019). Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. The International Journal of Biological Markers, 34(1), 60-68. https://doi.org/10.1177/1724600818820679
Vancouver
Ramphal W, Boeding JRE, van Iwaarden M, Schreinemakers JMJ, Rutten HJT, Crolla RMPH, et al. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. The International Journal of Biological Markers. 2019;34(1):60-68. doi:10.1177/1724600818820679
BibTeX
@article{Ramphal2019,
author = {Ramphal, Winesh and Boeding, Jeske R E and van Iwaarden, Maartje and Schreinemakers, Jennifer M J and Rutten, Harm J T and Crolla, Rogier M P H and Gobardhan, Paul D},
title = {Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer},
journal = {The International Journal of Biological Markers},
year = {2019},
volume = {34},
number = {1},
pages = {60--68},
doi = {10.1177/1724600818820679}
}
EUVIMED